We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$5.63M
Cap. Flow
-$22.7M
Cap. Flow %
-9.71%
Top 10 Hldgs %
77.03%
Holding
114
New
24
Increased
15
Reduced
9
Closed
6
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.24M
2
ATCO
Atlas Corp.
ATCO
+$963K
3
XRN.PRA icon
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
+$871K
4
KMB icon
Kimberly-Clark
KMB
+$733K
5
RXDX
Ignyta, Inc.
RXDX
+$698K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$25.4M
2
AGN
Allergan plc
AGN
+$2.3M
3
PFE icon
Pfizer
PFE
+$1.93M
4
ABBV icon
AbbVie
ABBV
+$1.35M
5
DD icon
Du Pont De Nemours E I
DD
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 70.4%
2 Financials 8.46%
3 Technology 4.23%
4 Real Estate 3.89%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BMY icon
76
Bristol-Myers Squibb
BMY
$124B
$142K 0.06%
2,225
+403
+22% +$23.5K
2017 Q1
2 quarters
BCTF
77
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
$140K 0.06%
10,000
– –
2016 Q4
3 quarters
XENE icon
78
Xenon Pharmaceuticals
XENE
$3.26B
$133K 0.06%
+45,000
New +$139K
2017 Q3
0 quarters
ORIT
79
DELISTED
Oritani Financial Corp. New
ORIT
$131K 0.06%
7,800
– –
2013 Q2
17 quarters
CUZ icon
80
Cousins Properties
CUZ
$4.53B
$125K 0.05%
3,357
– –
2015 Q1
10 quarters
FNB icon
81
FNB Corp
FNB
$6.14B
$125K 0.05%
8,905
– –
2014 Q3
12 quarters
EIGR
82
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$119K 0.05%
+360
New +$98.1K
2017 Q3
0 quarters
TST
83
DELISTED
TheStreet, Inc.
TST
$109K 0.05%
10,060
– –
2013 Q2
17 quarters
ARRY icon
84
DELISTED
Array Biopharma Inc
ARRY
$85K 0.04%
6,900
-21,500
-76% -$200K
2017 Q1
2 quarters
MDT icon
85
Medtronic
MDT
$121B
$82K 0.04%
1,050
– –
2014 Q3
12 quarters
CC icon
86
Chemours
CC
$1.92B
$68K 0.03%
1,360
– –
2015 Q3
8 quarters
F icon
87
Ford
F
$49.8B
$60K 0.03%
+5,000
New +$56.4K
2017 Q3
0 quarters
AIMT
88
DELISTED
Aimmune Therapeutics
AIMT
$50K 0.02%
+2,000
New +$43.1K
2017 Q3
0 quarters
OCRX
89
DELISTED
Ocera Therapeutics, Inc.
OCRX
$45K 0.02%
+39,800
New +$42.7K
2017 Q3
0 quarters
PKY
90
DELISTED
Parkway, Inc.
PKY
$39K 0.02%
1,678
– –
2017 Q1
2 quarters
LITS icon
91
Lite Strategy Inc
LITS
$35M
$38K 0.02%
+700
New +$38.8K
2017 Q3
0 quarters
AEHL icon
92
Antelope Enterprise Holdings
AEHL
$202M
– –
0
– –
2013 Q2
17 quarters
PBCT
93
DELISTED
People's United Financial Inc
PBCT
$27K 0.01%
1,500
– –
2015 Q1
10 quarters
BNS icon
94
Scotiabank
BNS
$111B
$26K 0.01%
400
– –
2015 Q1
10 quarters
LLY icon
95
Eli Lilly
LLY
$1.12T
$26K 0.01%
300
– –
2013 Q3
16 quarters
EXP icon
96
Eagle Materials
EXP
$5.19B
$24K 0.01%
228
– –
2013 Q2
17 quarters
JUNO
97
DELISTED
Juno Therapeutics, Inc.
JUNO
$24K 0.01%
+529
New +$18K
2017 Q3
0 quarters
ACAD icon
98
Acadia Pharmaceuticals
ACAD
$3.3B
$21K 0.01%
550
-30,397
-98% -$989K
2016 Q1
6 quarters
DBRG icon
99
DELISTED
DigitalBridge
DBRG
$18K 0.01%
367
– –
2017 Q1
2 quarters
ALNY icon
100
Alnylam Pharmaceuticals
ALNY
$31.2B
$13K 0.01%
+110
New +$9.39K
2017 Q3
0 quarters
1 2 3
4
5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2017 Portfolio in Review

As of Q3 2017, David M. Knott held 114 positions worth $234M, down 2.4% from $240M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott withdrew a net $22.7M in Q3 2017, closing 6 positions and reducing 9 holdings. Its most notable exit was Allergan plc, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, David M. Knott opened a new position in Atlas Corp. worth $993K.

  • David M. Knott's largest Q3 2017 buy was Atlas Corp.: 140,000 shares worth $993K.
  • David M. Knott added most to DuPont de Nemours in Q3 2017, an estimated $1.24M increase.
  • David M. Knott's biggest Q3 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $25.4M.
  • David M. Knott fully exited Allergan plc in Q3 2017, selling an estimated $2.3M.
  • David M. Knott's ten largest holdings make up 77% of its $234M portfolio in Q3 2017.
  • David M. Knott opened 24 new positions and closed 6 in Q3 2017.
  • David M. Knott's portfolio value fell 2.4% quarter-over-quarter to $234M.

Based on David M. Knott's 13F filing for Q3 2017, filed 13 Nov 2017.